X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4749) 4749
life sciences & biomedicine (4502) 4502
animals (3576) 3576
humans (2960) 2960
male (2576) 2576
glucagon-like peptide 1 (1772) 1772
endocrinology & metabolism (1670) 1670
glucagon (1613) 1613
rats (1514) 1514
pharmacology & pharmacy (1264) 1264
mice (1261) 1261
diabetes (1202) 1202
diabetes mellitus, type 2 - drug therapy (1156) 1156
female (1098) 1098
type 2 diabetes (1053) 1053
peptides (1009) 1009
insulin (968) 968
glucagon-like peptide 1 - metabolism (966) 966
glucagon-like peptide 1 - pharmacology (950) 950
glucose (945) 945
hypoglycemic agents - pharmacology (929) 929
glucagon-like peptide-1 receptor (927) 927
peptides - pharmacology (916) 916
insulin - metabolism (911) 911
peptide fragments - pharmacology (804) 804
glucagon-like peptide-1 (790) 790
hypoglycemic agents - therapeutic use (775) 775
blood glucose - metabolism (744) 744
glp-1 (709) 709
abridged index medicus (696) 696
insulin secretion (683) 683
adult (664) 664
glucagon-like peptide 1 - analogs & derivatives (625) 625
insulin - blood (620) 620
diabetes mellitus (593) 593
middle aged (575) 575
physiology (563) 563
venoms - pharmacology (563) 563
digestive, oral, and skin physiology (561) 561
physiological aspects (558) 558
liraglutide (535) 535
rats, sprague-dawley (532) 532
endocrine system (526) 526
mice, inbred c57bl (524) 524
biochemistry & molecular biology (523) 523
glucagon - pharmacology (511) 511
obesity (508) 508
research (505) 505
glucagon-like peptide 1 - blood (495) 495
analysis (489) 489
rats, wistar (468) 468
diabetes mellitus, type 2 - metabolism (464) 464
blood glucose - drug effects (460) 460
receptors, glucagon - metabolism (451) 451
hormones, hormone substitutes, and hormone antagonists (448) 448
dextrose (444) 444
rodents (441) 441
receptors, glucagon - agonists (424) 424
glucagon-like peptides (418) 418
dose-response relationship, drug (416) 416
insulin resistance (416) 416
cell line (415) 415
protein precursors - pharmacology (395) 395
glucagon-like peptide 1 - therapeutic use (387) 387
health aspects (385) 385
glucose - pharmacology (379) 379
glucose - metabolism (378) 378
exenatide (369) 369
cells, cultured (359) 359
glucagon - metabolism (357) 357
internal medicine (356) 356
islets of langerhans - metabolism (349) 349
glucagon-like peptide-1 receptor - agonists (348) 348
diabetes mellitus, type 2 - blood (347) 347
glucose tolerance test (344) 344
insulin-secreting cells - drug effects (343) 343
glucose metabolism (340) 340
insulin-secreting cells - metabolism (335) 335
islets of langerhans - drug effects (326) 326
signal transduction - drug effects (315) 315
dipeptidyl-peptidase iv inhibitors - pharmacology (314) 314
disease models, animal (305) 305
medicine & public health (304) 304
time factors (304) 304
medicine, research & experimental (302) 302
research & experimental medicine (302) 302
body weight (301) 301
signal transduction (301) 301
aged (299) 299
hypoglycemic agents - administration & dosage (293) 293
care and treatment (289) 289
neurosciences (289) 289
metabolism (286) 286
cyclic amp - metabolism (282) 282
hypoglycemic agents (280) 280
glucagon - blood (279) 279
blood glucose - analysis (278) 278
peptides - therapeutic use (278) 278
cell biology (274) 274
glucagon-like peptide-1 receptor - metabolism (266) 266
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5630) 5630
Japanese (58) 58
Chinese (35) 35
German (18) 18
French (14) 14
Spanish (12) 12
Hungarian (7) 7
Italian (6) 6
Czech (5) 5
Danish (5) 5
Portuguese (4) 4
Polish (3) 3
Russian (3) 3
Bosnian (1) 1
Dutch (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hypertension (Dallas, Tex. 1979), ISSN 1524-4563, 09/2012, Volume 60, Issue 3, pp. 833 - 841
Journal Article
PloS one, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e69010 - e69010
Journal Article
Atherosclerosis, ISSN 0021-9150, 04/2012, Volume 221, Issue 2, pp. 375 - 382
.... ► In summary, liraglutide can reduce oxidative stress and inflammation in HUVEC. Glucagon-like peptide 1 (GLP-1... 
Cardiovascular | Oxidative stress | NF-κB | Endothelial cell | Inflammation | Apoptosis | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Tumor Necrosis Factor-alpha - metabolism | Phosphorylation | Reactive Oxygen Species - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Membrane Glycoproteins - metabolism | Protein Kinase C-alpha - metabolism | Apoptosis - drug effects | Humans | NADPH Oxidases - metabolism | Human Umbilical Vein Endothelial Cells - immunology | NF-kappa B - metabolism | I-kappa B Proteins - metabolism | Dose-Response Relationship, Drug | C-Reactive Protein - metabolism | Transfection | I-kappa B Kinase - metabolism | Time Factors | Inflammation Mediators - metabolism | Superoxide Dismutase - metabolism | Recombinant Proteins - metabolism | Glutathione Peroxidase - metabolism | Human Umbilical Vein Endothelial Cells - drug effects | Anti-Inflammatory Agents - pharmacology | Glucagon-Like Peptide 1 - analogs & derivatives | Cells, Cultured | Glucagon-Like Peptide 1 - pharmacology | Antioxidants - pharmacology | NADPH Oxidase 2 | Protein Transport | Catalase - metabolism | NF-kappa B - genetics | Signal Transduction - drug effects | Serum Amyloid P-Component - metabolism | Oxidative Stress - drug effects | Liraglutide | Index Medicus
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 11/2011, Volume 339, Issue 2, pp. 464 - 473
...) possibly via taste receptor heterodimers, taste receptor type 1, member 1 (T1R1)/R3. We hypothesized that glucose-dependent insulinotropic peptide (GIP... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Receptors, Glucagon - antagonists & inhibitors | Gastric Inhibitory Polypeptide - metabolism | Receptors, G-Protein-Coupled - metabolism | Nitric Oxide Synthase - antagonists & inhibitors | Glucagon-Like Peptide 1 - blood | Male | Peptide Fragments - pharmacology | Receptors, Muscarinic - metabolism | Receptors, Gastrointestinal Hormone - metabolism | Exenatide | Receptors, Gastrointestinal Hormone - agonists | Glucagon-Like Peptide 2 - administration & dosage | Vasoactive Intestinal Peptide - pharmacology | Duodenum - metabolism | Peptide Fragments - blood | Inosine Monophosphate - administration & dosage | Gastric Inhibitory Polypeptide - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Receptors, Glucagon - agonists | Glucagon-Like Peptide 1 - metabolism | Glucagon-Like Peptide 2 - metabolism | Gastric Inhibitory Polypeptide - blood | Rats | Receptors, Glucagon - metabolism | Inosine Monophosphate - metabolism | Rats, Sprague-Dawley | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Receptors, Gastrointestinal Hormone - antagonists & inhibitors | Glutamic Acid - administration & dosage | Animals | Glucagon-Like Peptide-1 Receptor | Prostaglandin-Endoperoxide Synthases - metabolism | Glucagon-Like Peptide 2 - blood | Bicarbonates - metabolism | Glutamic Acid - metabolism | Nitric Oxide Synthase - metabolism | Receptors, Vasoactive Intestinal Peptide - antagonists & inhibitors | Venoms - pharmacology | Glucagon-Like Peptide 1 - antagonists & inhibitors | Duodenum - drug effects
Journal Article
by Ma, T and Du, X and Pick, J. E and Sui, G and Brownlee, M and Klann, E
The Journal of neuroscience, ISSN 1529-2401, 10/2012, Volume 32, Issue 40, pp. 13701 - 13708
...) and enhanced long-term depression induced by exogenous amyloid beta peptide A beta((1-42)). Similarly, hippocampal LTP impairments in amyloid precursor protein/presenilin 1 (APP/PS1... 
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Memory Disorders - physiopathology | Glycogen Synthase Kinase 3 - physiology | Reactive Oxygen Species - metabolism | Amyloid beta-Peptides - pharmacology | Neuronal Plasticity - drug effects | Glycogen Synthase Kinase 3 beta | Male | Peptide Fragments - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Ubiquinone - pharmacology | Excitatory Postsynaptic Potentials - physiology | CA3 Region, Hippocampal - drug effects | Amyloid beta-Peptides - genetics | CA3 Region, Hippocampal - metabolism | Organophosphorus Compounds - pharmacology | Female | Drug Evaluation, Preclinical | Alzheimer Disease - psychology | Disease Models, Animal | Alzheimer Disease - physiopathology | Glucagon-Like Peptide 1 - analogs & derivatives | Ubiquinone - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Presenilin-1 - genetics | Mice, Transgenic | Mitochondria - metabolism | Proto-Oncogene Proteins c-akt - physiology | Antioxidants - pharmacology | Mitochondria - drug effects | Association Learning - drug effects | Peptides - pharmacology | Fear | Antioxidants - therapeutic use | Animals | Memory Disorders - drug therapy | Signal Transduction - drug effects | Mice | Alzheimer Disease - genetics | Nootropic Agents - pharmacology | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Index Medicus
Journal Article
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 09/2014, Volume 136, Issue 37, pp. 12848 - 12851
... residues with conformationally constrained β-amino acid residues. This backbone-modification approach may be useful for developing stabilized analogues of other peptide... 
Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Type 2 diabetes | Care and treatment | Peptides | Glucagon | Analysis | Index Medicus | Residues | Surgical implants | Biomedical materials | In vivo testing | Surface chemistry | In vivo tests | Biocompatibility | Strategy | Communication
Journal Article